- Home
- MREO vs PAVM Comparison
MREO vs PAVM Comparison
Compare MREO & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | PAVM |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 41.1M |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MREO | PAVM |
|---|---|---|
| Price | $0.28 | $1.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $1.97 | ★ $36.50 |
| AVG Volume (30 Days) | ★ 624.0K | 8.3K |
| Earning Date | 11-17-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $500,000.00 | ★ $3,000,000.00 |
| Revenue This Year | N/A | $132.39 |
| Revenue Next Year | N/A | $263.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $0.20 | $0.21 |
| 52 Week High | $2.37 | $43.99 |
Technical Indicators
Market Signals| Indicator | MREO | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 21.84 |
| Support Level | $0.27 | N/A |
| Resistance Level | $0.35 | $6.56 |
| Average True Range (ATR) | 0.02 | 0.20 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 20.85 | 5.36 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.